课题基金 / 基金详情

项目摘要

项目成果

Marielle Yohe的其他基金

相似基金

相关文献

中文摘要
翻译
SMARCA 1在RMS组织中高度表达,但在肌肉组织中不表达。此外,我们发现SMARCA 1与HDAC 2在横纹肌肉瘤细胞中相互作用。SMARCA 1表达在肌源性分化过程中增加。CRISPR/Cas9用于敲除RH 30细胞中的SMARCA 1表达。我们正在制造SMARCA 1 KO RD细胞。我们将使用ATAC-seq来研究SMARCA 1 KO导致的染色质可及性的变化。此外,我们将检查SMARCA 1 KO对这些PAX融合阳性(RH 30)和阴性(RD)细胞分化的表型影响。该项目是与朱迪·戴维斯合作。
英文摘要
SMARCA1 is expressed highly in RMS tissues but not in muscle tissues. In addition, we show that SMARCA1 interacts with HDAC2 in rhabdomyosarcoma cells. SMARCA1 expression increases during myogenic differentiation. CRISPR/Cas9 was used to knock out SMARCA1 expression in RH30 cells. We are in the process of making SMARCA1 KO RD cells. We will use ATAC-seq to investigate changes in chromatin accessibility as a result of SMARCA1 KO. In addition, we will examine the phenotypic impact of SMARCA1 KO on the differentiation of these PAX-fusion positive (RH30) and negative (RD) cells. The project is in collaboration with Judy Davie.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dual Blockade of IGF1R and MEK synergistically inhibits pediatric cancers
  • 批准号:
    10486986
  • 项目类别:
  • 资助金额:
    $74.11万
  • 财政年份:
    --
  • 负责人:
    Marielle Yohe
  • 依托单位:
Targeting RAS in Pediatric Cancer
  • 批准号:
    10487040
  • 项目类别:
  • 资助金额:
    $22.23万
  • 财政年份:
    --
  • 负责人:
    Marielle Yohe
  • 依托单位:
Regulation of differentiation and invasion in RMS by ASAP1
  • 批准号:
    10702796
  • 项目类别:
  • 资助金额:
    $41.49万
  • 财政年份:
    --
  • 负责人:
    Marielle Yohe
  • 依托单位:
Advancing RAS and RASopathy Therapies
海外基金